You are here
Sleep Apnea Devices Market - Emerging Trends and Their Impact on Global Revenue Growth
The sleep apnea devices market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%.
The key factors propelling the growth of the market are increasing prevalence of sleep apnea globally owing to the increase of lifestyle diseases like obesity, initiatives by market players, the government to increase awareness regarding sleep apnea, and the various technological advancements brought about by players to make the products comfortable for patients and thus increase patient compliance and adherence to the treatment. Growing focus on home health and increasing preference for home sleep testing is likely to offer growth opportunities during the forecast period. Base year considered for the report is 2017 and the forecast period is 2018–2023.
By type, the sleep apnea diagnostic devices market is segmented into therapeutic and diagnostic devices. The therapeutic devices segment accounted for the largest share of the global sleep apnea market. Based on product, the sleep apnea therapeutic devices market is further segmented into positive airway pressure (PAP) devices, facial interfaces (masks), accessories, oral appliances, adaptive servo-ventilators (ASV), and other therapeutic devices (oxygen concentrators and airway clearance systems). The diagnostic devices segment is further segmented into polysomnography devices, home sleep testing devices, oximeters, actigraphy systems, and sleep screening devices. The polysomnography devices segment accounted for the largest share of the sleep apnea diagnostic devices market.
Download the PDF Brochure@
By end user, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care/individuals. The home care/individuals segment of the market is estimated to grow at the highest CAGR during the forecast period. This can be attributed to the preference for home care in sleep apnea diagnosed patients.
North America dominated the market in 2018
North America is expected to account for the largest share of the sleep apnea devices market in 2018, followed by Europe. The large share of this region can be attributed to the increasing obesity in the US which is in turn increasing the prevalence of sleep apnea, the high growth of the home sleep testing devices, and issuance of grants and funds by private and government institutions to promote awareness of sleep apnea as well as launch novel and technologically advanced products in the market space.
ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand) are the key players in the sleep apnea devices market. Other players involved in this market are SomnoMed (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Whole You (US), BMC Medical (China), Drive DeVilbiss Healthcare (US), and Braebon Medical (Canada).
Get the Sample Pages@
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.